The company called off the acquisition of Allergan after the U.S. Treasury issued the rule preventing the deal. Nevertheless, Chief Executive Officer Ian Read still has the investors support.
Ian Read
Breaking News
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- HYBE Files Police Report Against NewJeans Label CEO Min Hee-Jin Amid ADOR Exec's Emotional Press Conference
- Minneapolis City Council Unanimously Approves Minimum Retail Price of $15/Pack for Cigarettes to Improve Public Health
Pfizer said that net compensation of chief executive officer Ian Read declined 23% in 2015 driven by a drop in stock awards. The chief's net compensation amounted to $18 million in 2015.
Subscribe to VCpost newsletter
Most Popular
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- MSC Darwin Ship Targeted by Yemen's Houthis in Gulf of Aden
- JPMorgan CEO Warns of Economic Risks Amid Biden's 'Huge' Deficit Spending, Questions Likelihood of 'Soft Landing'
- Norway Airspace Shuts Down for Several Hours Following Technical Glitch
- Google's Parent Company Alphabet Approves First-Ever Dividend as Shares Skyrocket
